Displaying 73 - 83 of 83
Liver Tumours
5

Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020

View
Liver Tumours
5

Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Viral Hepatitis
4

AbbVie: How Can We Accelerate HCV Elimination in the Current Landscape? - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Displaying 73 - 83 of 83